Syneos Health Announces Strategic Collaboration and Investment in Indegene Omnipresence and the Company’s Next-Generation CRM and Omnichannel Engagement SaaS Platform
January 09, 2020 07:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced a strategic collaboration and...
Syneos Health to Present at the 38th Annual J.P. Morgan Healthcare Conference
January 03, 2020 17:59 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 03, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization)...
Syneos Health Insights Hub Releases 2020 Health Trends, Identifying Critical Shifts Impacting Drug Development and Commercialization
December 09, 2019 08:42 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Dec. 09, 2019 (GLOBE NEWSWIRE) -- The Syneos Health® Insights Hub, a dynamic destination for what’s next thinking and future-focused insights, today released 2020 Health Trends:...
Syneos Health Releases Report Identifying Barriers to Payer Use of RWE in Rare Disease and Recommendations for Advancing Payer Engagement
November 21, 2019 09:02 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C. and NEW YORK , Nov. 21, 2019 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released “Real World Value:...
Syneos Health to Present at the Jefferies 2019 London Healthcare Conference
November 13, 2019 08:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization)...
Bernadette Connaughton Appointed to Syneos Health Board of Directors
November 12, 2019 16:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading biopharmaceutical solutions organization combining a Contract Research Organization (CRO) and a Contract...
Syneos Health Reports Third Quarter 2019 Results
October 31, 2019 06:16 ET
|
Syneos Health, Inc.
Highlights GAAP revenue of $1,177.0 million for the three months ended September 30, 2019, representing growth of 5.6% compared to the same period in 2018.Adjusted revenue of $1,178.6 million for...
Syneos Health Schedules Third Quarter 2019 Earnings Call for Thursday, October 31, 2019
October 14, 2019 18:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 14, 2019 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization combining a Contract Research Organization...
Syneos Health Wins Society for Clinical Research Sites Eagle Award for Third Consecutive Year
October 14, 2019 14:19 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 14, 2019 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that the Company was awarded...
Syneos Health Introduces New Book, Why We Resist: The Surprising Truths About Motivating Behavior Change
September 30, 2019 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the launch of Why We Resist:...